(Q46429606)

22 December 2017

title

Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy (English)

1 reference

22 December 2017

0 references

N Fritz

1

1 reference

22 December 2017

S Glogau

2

1 reference

22 December 2017

J Hoffmann

3

1 reference

22 December 2017

M Rademacher

4

1 reference

22 December 2017

C E Elger

5

1 reference

22 December 2017

C Helmstaedter

6

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

published in

Epilepsy Behavior

1 reference

22 December 2017

volume

6

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

373-381

1 reference

22 December 2017

Topiramate: as monotherapy in newly diagnosed epilepsy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Selection criteria for the clinical use of the newer antiepileptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Neuropsychological effects of tiagabine, a potential new antiepileptic drug.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Effects of tiagabine monotherapy on abilities, adjustment, and mood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Cognitive impairments due to add-on therapy with topiramate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

The effects of adjunctive topiramate on cognitive function in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Cognitive and behavioral effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Effects of topiramate on cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Topiramate and word-finding difficulties in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Differential cognitive and behavioral effects of topiramate and valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Newer antiepileptic drugs and cognitive issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Cognitive side effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Safety of topiramate: adverse events and relationships to dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Topiramate titration and tolerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Effect of topiramate on attention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Postmarketing experience with topiramate and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

The assessment and analysis of handedness: The Edinburgh inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Interhemispheric differences in the localization of psychological processes in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Visual learning deficits in nonresected patients with right temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

A Rating Instrument For Anxiety Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.01.002

10.1016/J.YEBEH.2005.01.002

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017